{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:52:44Z","timestamp":1760921564843,"version":"3.40.5"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Vet Emergen Crit Care"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate changes in serum creatinine and chloride concentrations in anesthetized dogs that received 6% hydroxyethyl starch (HES) 670\/0.7.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective case series, 2002\u20132015.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>University veterinary teaching hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Animals<\/jats:title><jats:p>Two hundred forty\u2010four client\u2010owned dogs undergoing general anesthesia that received an HES solution.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>None.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements and Main Results<\/jats:title><jats:p>Medical records of dogs that received an HES solution (6%, 670\/0.7) while under general anesthesia during the study period were reviewed. Information obtained from the medical record included patient signalment, reason for anesthesia or diagnosis, body weight, amount of HES solution administered, pre\u2010 and postanesthesia creatinine value, pre\u2010 and postanesthesia chloride value, and day interval between measurements. Corrected chloride values were used for all statistical analysis. Dogs received a median dose of 6.3 mL\/kg hetastarch during anesthesia. Median preanesthesia creatinine and corrected chloride values were 79.5\u00a0\u03bcmol\/L (0.9\u00a0mg\/dL) (range 8.8\u2013689.5\u00a0\u03bcmol\/L [0.1\u20137.8\u00a0mg\/dL]) and 111\u00a0mmol\/L (111\u00a0mEq\/L) (range 80\u2013123\u00a0mmol\/L [80\u2013123\u00a0mg\/dL]), respectively. Median postanesthesia creatinine was 57.4\u00a0\u03bcmol\/L (0.65\u00a0mg\/dL) (8.8\u2013716\u00a0\u03bcmol\/L [0.1\u20138.1\u00a0mg\/dL]). Median postanesthesia corrected chloride was 115\u00a0mmol\/L (115\u00a0mEq\/L) (range 87.5\u2013129.6\u00a0mmol\/L [87.5\u2013129.6\u00a0mEq\/L]). Mann\u2013Whitney test analysis revealed a significant decrease in creatinine (\u0394 Cr 17.7\u00a0\u03bcmol\/L [0.2\u00a0mg\/dL], <jats:italic>P<\/jats:italic> &lt; 0.01) and a significant increase in corrected chloride (\u0394 Cl 4.1\u00a0mmol\/L [4.1mEq\/L], <jats:italic>P<\/jats:italic> &lt; 0.01) between pre\u2010 and postanesthesia values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In a mixed population of hospitalized dogs undergoing general anesthesia that received a median dose of 6 mL\/kg of HES, creatinine was lower and chloride was higher in the postanesthetic than in the preanesthetic period. The clinical significance of these changes and the role that HES administration played in them relative to concurrent therapies is unknown.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vec.12836","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:36:45Z","timestamp":1557301005000},"page":"309-313","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Retrospective evaluation of paired plasma creatinine and chloride concentrations following hetastarch administration in anesthetized dogs (2002\u20132015): 244 cases"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0327-8537","authenticated-orcid":false,"given":"Kristin M.","family":"Zersen","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Colorado State University  Fort Collins CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khursheed","family":"Mama","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Colorado State University  Fort Collins CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin C.","family":"Mathis","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Colorado State University  Fort Collins CO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12208"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2004.65.1189"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.70.11.1345"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-4431.2005.00138.x"},{"key":"e_1_2_8_6_1","first-page":"200","article-title":"Efficacy and adverse effects of hetastarch\/crystalloid combination in 16 hypotensive dogs","volume":"12","author":"Garcia AM","year":"2002","journal-title":"J Vet Emerg Crit Care."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12412"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.12492"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-4431.2012.00816.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12320"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12483"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318256be72"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cacc.2006.03.007"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200201000-00046"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199905000-00007"},{"key":"e_1_2_8_16_1","first-page":"F734","article-title":"Release of renin and angiotensin II into plasma and lymph during hyperchloremia","volume":"253","author":"Wilcox CS","year":"1987","journal-title":"Am J Physiol."},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1172\/JCI110820","article-title":"Regulation of renal blood flow by plasma chloride","volume":"71","author":"Wilcox CS","journal-title":"J Clin Invest."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13447.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.13356"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2010.0552.x"},{"key":"e_1_2_8_21_1","first-page":"CD001319","article-title":"Colloid solutions for fluid resuscitation","author":"Bunn F","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_22_1","first-page":"CD007594","article-title":"Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function","author":"Mutter TC","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209759"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.430"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242"}],"container-title":["Journal of Veterinary Emergency and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvec.12836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vec.12836","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vec.12836","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vec.12836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T17:49:12Z","timestamp":1694368152000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vec.12836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/vec.12836"],"URL":"https:\/\/doi.org\/10.1111\/vec.12836","archive":["Portico"],"relation":{},"ISSN":["1479-3261","1476-4431"],"issn-type":[{"type":"print","value":"1479-3261"},{"type":"electronic","value":"1476-4431"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"2016-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}